Andre Jacques Auberton Herve

Insider Reports History

Entity
Individual
Location
18 Chemin De La Vierge Noire, La Tronche, France
Signature
/s/ Andre-Jacques Auberton-Herve
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andre Jacques Auberton Herve:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Chavant Capital Acquisition Corp. Director Class A Common Stock 541K $5.41M $10.00 Dec 21, 2023 Indirect
Bionik Laboratories Corp. Director Common Stock 1.11M $666K $0.60 Jun 13, 2023 Shares held through Star SCI
Chavant Capital Acquisition Corp. Director Class A Common Stock 27.8K $278K $10.00 Dec 21, 2023 Direct
Bionik Laboratories Corp. Director Common Stock 95.1K $57.1K $0.60 Jun 13, 2023 Direct
Bionik Laboratories Corp. Director Common Stock 10.7K $6.42K $0.60 Jun 13, 2023 Shares held through 4A Consulting and Engineering
Chavant Capital Acquisition Corp. Director Make-Whole Shares (right to acquire) 145K Dec 21, 2023 Indirect
Bionik Laboratories Corp. Director Convertible Promissory Note 1 Jun 13, 2023 Through Star SCI

Insider Reports Filed by Andre Jacques Auberton Herve

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MOBX Chavant Capital Acquisition Corp. Dec 21, 2023 3 $1.45M 4 Dec 26, 2023 Director
BNKL Bionik Laboratories Corp. Jun 13, 2023 2 $332K 4 Jun 21, 2023 Director
BNKL Bionik Laboratories Corp. Jun 9, 2023 1 $390K 4 Jun 21, 2023 Director
CLAY Chavant Capital Acquisition Corp. Feb 24, 2022 1 $0 4 Feb 28, 2022 Director
CLAY Chavant Capital Acquisition Corp. Jul 19, 2021 0 $0 3 Jul 20, 2021 Director
BNKL Bionik Laboratories Corp. Jul 15, 2021 4 $210K 4 Jun 21, 2022 Director